2027 年北美肾病市场预测 - COVID-19 影响和按产品划分的区域分析(诊断和治疗);最终用户(医院、诊断实验室等);和国家

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 142    |    Report Code: TIPRE00016072    |    Category: Life Sciences

North America Kidney Disease Market

市场介绍

肾脏病又称肾病。这是由于肾脏功能失调引起的。肾脏疾病有多种类型,包括肾结石、肾小球肾炎、尿路感染等。为了治疗和诊断这些类型的疾病,不同的全球和地区参与者正在提供各种产品和服务。

 

市场概况和动态< /u>

北美肾脏疾病市场预计将从 2019 年的 254.835 亿美元增至 2027 年的 424.621 亿美元。预计从 2020 年开始,该市场将以 6.7% 的复合年增长率增长-2027。市场的增长归因于一些关键驱动因素,例如慢性肾脏相关疾病的患病率增加和人口老龄化的高速增长。然而,由于肾脏疾病诊断失败,预计市场在预测期内增长缓慢。

主要细分市场

从产品来看,肾病市场细分诊断和治疗。诊断部分进一步细分为血液检查、尿液检查、影像检查等。治疗部分进一步细分为透析、药物类别等。该药物类别细分为 ACE 抑制剂、血管紧张素 2 受体阻滞剂、利尿剂等。根据最终用户,肾脏疾病市场分为医院、诊断实验室等。

 

主要来源和上市公司

报告中包含的一些主要的肾脏疾病市场主要来源包括美国泌尿外科协会、国家肾脏基金会肾脏国际报告< span> 和其他

 < /strong>

购买报告的理由

  • 了解北美肾脏疾病市场格局并确定最有可能保证强劲回报的细分市场
  • 保持领先地位了解肾脏疾病市场不断变化的竞争格局
  • 通过识别最有可能销售前景的细分市场,有效规划北美肾脏疾病市场的并购和合作交易< /li>
  • 通过对肾脏疾病市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • 通过以下方式获取市场的市场收入预测2019年至2027年北美地区各个细分市场

 

北美肾病市场细分

 

按产品

·        诊断

o      血液测试

o      尿液测试

o     成像测试

o      其他

·        治疗

o      透析

o      其他

o      药物类别

§   ACE抑制剂

§   血管紧张素-II 受体阻滞剂

§   利尿剂

§   其他

 

最终用户

·     ;     医院

·         诊断实验室

·        其他

按国家/地区

·        北美

o      美国

o      加拿大

o      墨西哥

公司简介

  • 雅培
  • F.霍夫曼-拉罗氏有限公司
  • 艾伯维公司
  • 辉瑞公司
  • 梯瓦制药工业公司有限公司
  • 葛兰素史克公司
  • 安进公司
  • 希森美康公司
  • < li class=\"MsoNormalCxSpMiddle\">西门子股份公司
 

North America Kidney Disease Strategic Insights

Strategic insights for North America Kidney Disease involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-kidney-disease-market-strategic-framework.webp
Get more information on this report

North America Kidney Disease Report Scope

Report Attribute Details
Market size in 2019 US$ 25,483.5 Million
Market Size by 2027 US$ 42,462.1 Million
Global CAGR (2020 - 2027) 6.7%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 产品
  • 诊断和治疗
By 最终用户
  • 医院
  • 诊断实验室
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Amgen Inc.
  • Sysmex Corporation
  • Siemens AG
  • Get more information on this report

    North America Kidney Disease Regional Insights

    The regional scope of North America Kidney Disease refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-kidney-disease-market-geography.webp
    Get more information on this report

    The List of Companies - North America Kidney Disease Market

    The List of Companies - North America Kidney Disease Market

    1. Abbott
    2. F. Hoffmann-La Roche Ltd
    3. AbbVie Inc.
    4. Pfizer Inc.
    5. Teva Pharmaceutical Industries Ltd
    6. GlaxoSmithKline plc.
    7. Amgen Inc.
    8. Sysmex Corporation
    9. Siemens AG
    Frequently Asked Questions
    How big is the North America Kidney Disease Market?

    The North America Kidney Disease Market is valued at US$ 25,483.5 Million in 2019, it is projected to reach US$ 42,462.1 Million by 2027.

    What is the CAGR for North America Kidney Disease Market by (2020 - 2027)?

    As per our report North America Kidney Disease Market, the market size is valued at US$ 25,483.5 Million in 2019, projecting it to reach US$ 42,462.1 Million by 2027. This translates to a CAGR of approximately 6.7% during the forecast period.

    What segments are covered in this report?

    The North America Kidney Disease Market report typically cover these key segments-

  • 产品 (诊断和治疗)
  • 最终用户 (医院, 诊断实验室)
  • What is the historic period, base year, and forecast period taken for North America Kidney Disease Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Kidney Disease Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in North America Kidney Disease Market?

    The North America Kidney Disease Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Amgen Inc.
  • Sysmex Corporation
  • Siemens AG
  • Who should buy this report?

    The North America Kidney Disease Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Kidney Disease Market value chain can benefit from the information contained in a comprehensive market report.